Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Feb 1:2016:bcr2015211673.
doi: 10.1136/bcr-2015-211673.

Successful treatment of Sydenham's chorea with intravenous immunoglobulin

Nienke Anne Boersma  1 , Herman Schippers  2 , Taco Kuijpers  3 , Jojanneke Heidema  4
Affiliations
Case Reports

Successful treatment of Sydenham's chorea with intravenous immunoglobulin

Nienke Anne Boersma et al. BMJ Case Rep. .

Abstract

We present a case of a 10-year-old girl diagnosed with Sydenham's chorea. Despite treatment with haloperidol and valproic acid for 2 weeks and antibiotics for 5 days, her symptoms continued to worsen. She became severely impaired in daily functioning, as she could barely speak or walk, experienced major feeding difficulties and required help with all daily activities. She was treated with intravenous immunoglobulin (IVIG). Within 4 days, her symptoms started to improve and after 1-month she had fully recovered. This case reminds us that Sydenham's chorea can result in major functional impairment. There is some evidence on the beneficial effect of IVIG in the treatment of Sydenham's chorea, as is evident in our case. Therefore, IVIG should be considered as a treatment option in patients with severe chorea.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Therapeutic aspects of Sydenham's Chorea: an update.
    Depietri G, Carli N, Sica A, Oliviero D, Costagliola G, Striano P, Bonuccelli A, Frisone F, Peroni D, Consolini R, Foiadelli T, Orsini A. Depietri G, et al. Acta Biomed. 2022 Mar 21;92(S4):e2021414. doi: 10.23750/abm.v92iS4.12663. Acta Biomed. 2022. PMID: 35441610 Free PMC article. Review.
  • Treatment of Sydenham's Chorea: A Review of the Current Evidence.
    Dean SL, Singer HS. Dean SL, et al. Tremor Other Hyperkinet Mov (N Y). 2017 Jun 1;7:456. doi: 10.7916/D8W95GJ2. eCollection 2017. Tremor Other Hyperkinet Mov (N Y). 2017. PMID: 28589057 Free PMC article. Review.
  • Treatments and Outcomes Among Patients with Sydenham Chorea: A Meta-Analysis.
    Eyre M, Thomas T, Ferrarin E, Khamis S, Zuberi SM, Sie A, Newlove-Delgado T, Morton M, Molteni E, Dale RC, Lim M, Nosadini M; Sydenham’s Chorea Systematic Literature Review Working Group. Eyre M, et al. JAMA Netw Open. 2024 Apr 1;7(4):e246792. doi: 10.1001/jamanetworkopen.2024.6792. JAMA Netw Open. 2024. PMID: 38625703 Free PMC article.

References

    1. Zomorrodi A, Wald ER. Sydenham's chorea in western Pennsylvania. Pediatrics 2006;117:e675–9. 10.1542/peds.2005-1573 - DOI - PubMed
    1. Korn-Lubetzki I, Brand A, Steiner I. Recurrence of Sydenham chorea: implications for pathogenesis. Arch Neurol 2004;61:1261–4. 10.1001/archneur.61.8.1261 - DOI - PubMed
    1. Demiroren K, Yavuz H, Cam L et al. . Sydenham's chorea: a clinical follow-up of 65 patients. J Child Neurol 2007;22:550–4. 10.1177/0883073807302614 - DOI - PubMed
    1. Carapetis JR, Currie BJ. Rheumatic chorea in northern Australia: a clinical and epidemiological study. Arch Dis Child 1999;80:353–8. 10.1136/adc.80.4.353 - DOI - PMC - PubMed
    1. Walker AR, Tani LY, Thompson JA et al. . Rheumatic chorea: relationship to systemic manifestations and response to corticosteroids. J Pediatr 2007;151:679–83. 10.1016/j.jpeds.2007.04.059 - DOI - PubMed

Publication types